UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000020061 |
|---|---|
| Receipt number | R000023174 |
| Scientific Title | Standardization of Bio-Psycho-Social tests for healthy Japanese |
| Date of disclosure of the study information | 2016/01/04 |
| Last modified on | 2023/01/04 20:50:50 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Standardization of Bio-Psycho-Social tests for healthy Japanese
Acronym
Bio-Psycho-Social tests for healthy Japanese
Scientific Title
Standardization of Bio-Psycho-Social tests for healthy Japanese
Scientific Title:Acronym
Bio-Psycho-Social tests for healthy Japanese
Region
| Japan |
Condition
Condition
Healthy Japanese
Classification by specialty
| Adult | Child |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To standardize bio-psycho-social tests' result for healthy Japanese
Basic objectives2
Others
Basic objectives -Others
Standardization
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
eye-movement test, event-related potential(ERP),neuro-cognitive-battery, social-cognitive-battery, MRI, SPECT, PET, social background
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 13 | years-old | <= |
Age-upper limit
| 70 | years-old | > |
Gender
Male and Female
Key inclusion criteria
Healthy Japanese
Key exclusion criteria
Person who cannot endure the tests
Target sample size
120
Research contact person
Name of lead principal investigator
| 1st name | Ichiro |
| Middle name | |
| Last name | Kusumi |
Organization
Hokkaido University Graduate School of Medicine
Division name
Department of Psychiatry
Zip code
060-8638
Address
Kita 15 Nishi 7, Kita-ku, Sapporo, Hokkaido
TEL
0117065160
hashimona@gmail.com
Public contact
Name of contact person
| 1st name | Naoki |
| Middle name | |
| Last name | Hashimoto |
Organization
Hokkaido University, Graduate School of Medicine
Division name
Department of Psychiatry
Zip code
060-8638
Address
Kita 15 Nishi 7, Kita-ku, Sapporo, Hokkaido
TEL
0117065160
Homepage URL
hashinao@med.hokudai.ac.jp
Sponsor or person
Institute
Department of Psychiatry, Hokkaido University Graduate School of Medicine
Institute
Department
Personal name
Funding Source
Organization
No
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
The Hokkaido University Hospital Ethics Committee
Address
Kita14 Nishi5, Kita-ku, Sapporo, Hokkaido
Tel
011-706-7934
recjimu@huhp.hokudai.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
北海道大学病院
Other administrative information
Date of disclosure of the study information
| 2016 | Year | 01 | Month | 04 | Day |
Related information
URL releasing protocol
https://pubmed.ncbi.nlm.nih.gov/29201642/
Publication of results
Published
Result
URL related to results and publications
https://pubmed.ncbi.nlm.nih.gov/29201642/
Number of participants that the trial has enrolled
240
Results
Two hundred and forty healthy subjects were included.
They were used as controls in a comparative study with schizophrenic patients recruited in another study, which showed that schizophrenic patients had smaller hippocampal volume and larger globus pallidus volume than normal subjects, and that antipsychotic drugs were involved in the volume changes.
Results date posted
| 2023 | Year | 01 | Month | 04 | Day |
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Two hundred and forty healthy Japanese subjects were included in the study.
Participant flow
Psychosocial evaluation, psychiatric symptom evaluation, brain imaging, and neurophysiological testing were performed on healthy subjects who gave consent.
Adverse events
No serious adverse events observed.
Outcome measures
Psychosocial evaluation, psychiatric symptom evaluation, brain imaging, and neurophysiological testing
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2010 | Year | 04 | Month | 28 | Day |
Date of IRB
| 2010 | Year | 07 | Month | 15 | Day |
Anticipated trial start date
| 2010 | Year | 08 | Month | 01 | Day |
Last follow-up date
| 2017 | Year | 04 | Month | 27 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Design:Prospective observational study
Recruit:Healthy Japanese are recruiting from the community mainly through posters.
Items: demographic background, event related potential, structural MRI, functional MRI, social cognition, neurocognition, eye movement
Management information
Registered date
| 2015 | Year | 12 | Month | 03 | Day |
Last modified on
| 2023 | Year | 01 | Month | 04 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023174
